Despite screening being an important tool in the early detection of prostate cancer, the findings in the review highlight that up to 70.3% of respondents can be unaware of the availability of any screening tests for prostate cancer [92], and less than half at age 50 experienced a lifetime PSA screening event [35]. The gene discussed is KLK3; the disease is prostate cancer.